Literature DB >> 11924605

Axonal transport of neurofilaments in normal and disease states.

C C J Miller1, S Ackerley, J Brownlees, A J Grierson, N J O Jacobsen, P Thornhill.   

Abstract

Neurofilaments are among the most abundant organelles in neurones. They are synthesised in cell bodies and then transported into and through axons by a process termed 'slow axonal transport' at a rate that is distinct from that driven by conventional fast motors. Several recent studies have now demonstrated that this slow rate of transport is actually the consequence of conventional fast rates of movement that are interrupted by extended pausing. At any one time, most neurofilaments are thus stationary. Accumulations of neurofilaments are a pathological feature of several human neurodegenerative diseases suggesting that neurofilament transport is disrupted in disease states. Here, we review recent advances in our understanding of neurofilament transport in both normal and disease states. Increasing evidence suggests that phosphorylation of neurofilaments is a mechanism for regulating their transport properties, possibly by promoting their detachment from the motor(s). In some neurodegenerative diseases, signal transduction mechanisms involving neurofilament kinases and phosphatases may be perturbed leading to disruption of transport.

Entities:  

Mesh:

Year:  2002        PMID: 11924605     DOI: 10.1007/s00018-002-8425-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  23 in total

1.  Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Cargo distributions differentiate pathological axonal transport impairments.

Authors:  Cassie S Mitchell; Robert H Lee
Journal:  J Theor Biol       Date:  2012-01-25       Impact factor: 2.691

3.  Gel-expanded to gel-condensed transition in neurofilament networks revealed by direct force measurements.

Authors:  Roy Beck; Joanna Deek; Jayna B Jones; Cyrus R Safinya
Journal:  Nat Mater       Date:  2009-11-15       Impact factor: 43.841

Review 4.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

5.  Selective hair cell ablation and noise exposure lead to different patterns of changes in the cochlea and the cochlear nucleus.

Authors:  Takaomi Kurioka; Min Young Lee; Amarins N Heeringa; Lisa A Beyer; Donald L Swiderski; Ariane C Kanicki; Lisa L Kabara; David F Dolan; Susan E Shore; Yehoash Raphael
Journal:  Neuroscience       Date:  2016-07-09       Impact factor: 3.590

Review 6.  RNA-binding proteins associated molecular mechanisms of motor neuron degeneration pathogenesis.

Authors:  Anna Y Tang
Journal:  Mol Biotechnol       Date:  2014-09       Impact factor: 2.695

7.  Acrylamide Retards the Slow Axonal Transport of Neurofilaments in Rat Cultured Dorsal Root Ganglia Neurons and the Corresponding Mechanisms.

Authors:  Lihong An; Guozhen Li; Jiliang Si; Cuili Zhang; Xiaoying Han; Shuo Wang; Lulu Jiang; Keqin Xie
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

Review 8.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

9.  Liquid crystal assemblies in biologically inspired systems.

Authors:  Cyrus R Safinya; Joanna Deek; Roy Beck; Jayna B Jones; Cecilia Leal; Kai K Ewert; Youli Li
Journal:  Liq Cryst       Date:  2013-01-01

Review 10.  Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.

Authors:  Mala V Rao; Ralph A Nixon
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.